Papamarkou Wellner Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Papamarkou Wellner Asset Management's REGN Position: Q2 2026 in Review
Papamarkou Wellner Asset Management held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 382 shares worth $238K. The position accounts for 0.15% of the portfolio, ranked #66.
Papamarkou Wellner Asset Management first reported a position in REGN in Q1 2025 and has held it in 5 quarters since. The position peaked at $295K in Q1 2026. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Papamarkou Wellner Asset Management held 382 shares of Regeneron Pharmaceuticals worth $238K as of Q2 2026.
- Papamarkou Wellner Asset Management left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
- Regeneron Pharmaceuticals made up 0.15% of Papamarkou Wellner Asset Management's portfolio in Q2 2026, its #66 holding.
- Papamarkou Wellner Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
- Papamarkou Wellner Asset Management's Regeneron Pharmaceuticals position peaked at $295K in Q1 2026.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Papamarkou Wellner Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.